{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:50:06Z","timestamp":1791474606159,"version":"4.3.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":1118,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council Singapore","doi-asserted-by":"crossref","award":["NMRC\/1227\/2009"],"award-info":[{"award-number":["NMRC\/1227\/2009"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1093\/annonc\/mdw415","type":"journal-article","created":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T01:20:00Z","timestamp":1475112000000},"page":"2210-2215","source":"Crossref","is-referenced-by-count":55,"title":["A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)"],"prefix":"10.1016","volume":"27","author":[{"given":"W.M.","family":"Tai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.P.","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.S.","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.K.","family":"Tham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.S.","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.S.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.W.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.Z.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hartano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.H.","family":"Thng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.T.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.C.","family":"Toh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.C.","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.P.","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1093\/annonc\/mdw415_bb0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1093\/annonc\/mdw415_bb0015","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1093\/annonc\/mdw415_bb0020","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1053\/j.gastro.2006.01.006","article-title":"Ubiquitous activation of Ras and Jak\/Stat pathways in human HCC","volume":"130","author":"Calvisi","year":"2006","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1093\/annonc\/mdw415_bb0025","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/hep.510270409","article-title":"Activation of mitogen-activated protein kinases\/extracellular signal-regulated kinases in human hepatocellular carcinoma","volume":"27","author":"Ito","year":"1998","journal-title":"Hepatology"},{"issue":"1","key":"10.1093\/annonc\/mdw415_bb0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.critrevonc.2008.02.009","article-title":"Growth factors as therapeutic targets in HCC","volume":"67","author":"Furuse","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1093\/annonc\/mdw415_bb0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1158\/0008-5472.CAN-08-2144","article-title":"NORE1B is a putative tumor suppressor in hepatocarcinogenesis and may act via RASSF1A","volume":"69","author":"Macheiner","year":"2009","journal-title":"Cancer Res"},{"issue":"5","key":"10.1093\/annonc\/mdw415_bb0040","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jhep.2006.06.014","article-title":"Deregulation of the activin\/follistatin system in hepatocarcinogenesis","volume":"45","author":"Grusch","year":"2006","journal-title":"J Hepatol"},{"issue":"1","key":"10.1093\/annonc\/mdw415_bb0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jhep.2009.10.008","article-title":"AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)","volume":"52","author":"Huynh","year":"2010","journal-title":"J Hepatol"},{"issue":"4","key":"10.1093\/annonc\/mdw415_bb0050","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nprot.2007.111","article-title":"A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood","volume":"2","author":"Duda","year":"2007","journal-title":"Nat Protoc"},{"issue":"7","key":"10.1093\/annonc\/mdw415_bb0055","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.20060468","article-title":"Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells","volume":"203","author":"Seddiki","year":"2006","journal-title":"J Exp Med"},{"issue":"7","key":"10.1093\/annonc\/mdw415_bb0060","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J Exp Med"},{"issue":"9","key":"10.1093\/annonc\/mdw415_bb0065","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/nbm.1680","article-title":"A comparative study of dynamic contrast-enhanced MRI parameters as biomarkers for anti-angiogenic drug therapy","volume":"24","author":"Koh","year":"2011","journal-title":"NMR Biomed"},{"issue":"4","key":"10.1093\/annonc\/mdw415_bb0070","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1158\/1078-0432.CCR-14-1901","article-title":"Antitumor activity in RAS-driven tumors by blocking AKT and MEK","volume":"21","author":"Tolcher","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"17","key":"10.1093\/annonc\/mdw415_bb0075","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1200\/JCO.2010.33.9432","article-title":"Phase II study of the mitogen-activated protein kinase 1\/2 inhibitor selumetinib in patients with advanced hepatocellular carcinoma","volume":"29","author":"O'Neil","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1093\/annonc\/mdw415_bb0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"issue":"23","key":"10.1093\/annonc\/mdw415_bb0085","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1158\/1078-0432.CCR-13-3445","article-title":"A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinoma","volume":"20","author":"Lim","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1093\/annonc\/mdw415_bb0090","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00262-012-1380-8","article-title":"Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma","volume":"62","author":"Cabrera","year":"2013","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"10.1093\/annonc\/mdw415_bb0095","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/imm.12397","article-title":"MEK inhibition prevents tumour-shed transforming growth factor-beta-induced T-regulatory cell augmentation in tumour milieu","volume":"144","author":"Hossain","year":"2015","journal-title":"Immunology"},{"issue":"3","key":"10.1093\/annonc\/mdw415_bb0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2217\/imt.15.126","article-title":"Rationally combining anti-VEGF therapy with checkpoint inhibitors in hepatocellular carcinoma","volume":"8","author":"Hato","year":"2016","journal-title":"Immunotherapy"},{"issue":"5","key":"10.1093\/annonc\/mdw415_bb0105","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/hep.27665","article-title":"CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice","volume":"61","author":"Chen","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1093\/annonc\/mdw415_bb0110","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccr.2005.09.005","article-title":"Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors","volume":"8","author":"Casanovas","year":"2005","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1093\/annonc\/mdw415_bb0115","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ccr.2009.01.027","article-title":"Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis","volume":"15","author":"Paez-Ribes","year":"2009","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1093\/annonc\/mdw415_bb0120","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ccr.2009.01.021","article-title":"Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis","volume":"15","author":"Ebos","year":"2009","journal-title":"Cancer Cell"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341936538X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341936538X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/27\/12\/2210\/13789471\/mdw415.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T08:02:39Z","timestamp":1624694559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341936538X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S092375341936538X"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdw415","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}